First Turn Management »

Glaukos shares owned by First Turn Management

Quarter-by-quarter ownership of Glaukos (GKOS) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Glaukos

Tip: Access up to 7 years of quarterly data

All positions including Glaukos held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Glaukos by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 96k 130.28

More positions owned by First Turn Management

Nuvalent Inc-a (NUVL)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Vaxcyte (PCVX)
Axsome Therapeutics (AXSM)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Natera (NTRA)
Intra Cellular Therapies (ITCI)
Crinetics Pharmaceuticals In (CRNX)
Transmedics Group (TMDX)
Arcellx Common Stock (ACLX)
Blueprint Medicines (BPMC)
Verona Pharma Sponsored Ads (VRNA)

View all positions for First Turn Management

Top funds holding Glaukos

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Brown Capital Management
Henderson Group
Invesco
Lord, Abbett & Co
PRIMECAP Management Company
Geode Capital Management
Fred Alger Management
Driehaus Capital Management
Artisan Partners Limited Partnership
Charles Schwab Investment Management
Morgan Stanley

View all funds holding Glaukos